AOD9604 (Anti-Obesity Drug 9604) is a synthetic peptide fragment derived from the C-terminal end of human growth hormone (hGH). Its proposed effects on the body are primarily related to , based on preclinical research and limited human studies. However, it's crucial to understand:
1.Proposed Mechanisms of Action:
It may activate enzymes (hormone-sensitive lipase) in fat cells (adipocytes), promoting the breakdown of stored triglycerides into free fatty acids for energy.
It may block the conversion of glucose and other precursors into new triglycerides for storage in fat cells.
AOD9604 is thought to influence metabolic pathways (potentially via cAMP signaling) to shift the body towards using fat as fuel.
research (mostly in cells and animals) suggested it might stimulate chondrocyte (cartilage cell) growth and collagen synthesis, hinting at possible benefits for joint health. This is far less established than the metabolic effects.
2.Claimed/Potential Benefits (Based on Limited Evidence):
The primary historical claim, especially targeting stubborn abdominal fat.
Often marketed alongside fat reduction claims.
Suggested to boost calorie burning.
Some anecdotal reports exist, but robust evidence is lacking.
Based on very early-stage research; not proven in humans for therapeutic use.
3.Critical Considerations & Current Status:
no large-scale, rigorous, peer-reviewed clinical trials have definitively proven its efficacy and safety for weight loss or fat reduction in humans. Much of the evidence comes from animal or cell studies.
○Not FDA-Approved: AOD9604 for the treatment of obesity, weight loss, fat reduction, or any other medical condition.
It is primarily available as a "research chemical" or compounded by specialized pharmacies. Its legal status varies significantly by country and region.
Long-term safety data in humans is lacking. Reported side effects in limited use are often mild and injection-site related (redness, itching, swelling), but potential systemic risks are unknown without proper trials.
○Marketing vs. Reality: Claims about its effectiveness, especially dramatic fat loss, are often significantly exaggerated based on the current level of scientific evidence.
AOD9604 is a synthetic peptide fragment that, based on its structure and early research, to work by stimulating fat breakdown and inhibiting fat storage. Its primary claimed effect is . However, robust scientific evidence proving its effectiveness and long-term safety in humans for these purposes is currently lacking. It remains an experimental compound not approved for medical use by major regulatory agencies.
If you are considering using AOD9604, consult a qualified healthcare professional. Do not rely on marketing claims. Be aware of the regulatory status and potential risks in your region. Proven methods for fat loss and weight management remain diet, exercise, and FDA-approved medications prescribed by a doctor.
https://www.hormonerawsource.com/peptides/aod9604-2mg-vial-for-bodybuilding-cas-221231.html
